Document/ExhibitDescriptionPagesSize 1: 8-K Current Report HTML 45K
6: R1 Cover HTML 47K
8: XML IDEA XML File -- Filing Summary XML 11K
11: XML XBRL Instance -- adnt-20240312_htm XML 14K
7: EXCEL IDEA Workbook of Financial Report Info XLSX 8K
3: EX-101.DEF XBRL Definitions -- adnt-20240312_def XML 40K
4: EX-101.LAB XBRL Labels -- adnt-20240312_lab XML 75K
5: EX-101.PRE XBRL Presentations -- adnt-20240312_pre XML 40K
2: EX-101.SCH XBRL Schema -- adnt-20240312 XSD 10K
9: JSON XBRL Instance as JSON Data -- MetaLinks 14± 19K
10: ZIP XBRL Zipped Folder -- 0001670541-24-000058-xbrl Zip 18K
Registrant’s telephone number, including area code: i734-i254-5000
Not
applicable
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of class
Trading symbol(s)
Name of exchange on which registered
iOrdinary
Shares, par value $0.001
iADNT
iNew York Stock Exchange
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
registrants under any of the following provisions (see General Instruction A.2. below):
i☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i☐ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i☐ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company i☐
If
an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders.
Adient plc (“Adient”) held its 2024 Annual General Meeting on March 12, 2024. The independent inspector of elections for the 2024 Annual General Meeting delivered its final tabulation of
voting results for each of the matters submitted to a vote of shareholders at the 2024 Annual General Meeting, certifying on March 12, 2024 the voting results set forth below.
Proposal One:
Adient’s shareholders elected, by separate resolutions, the following nine directors for a period of one year, expiring at the end of Adient’s Annual General Meeting of Shareholders in 2025, by the following votes:
Nominee
For
Against
Abstain
Broker
Non-Vote
Julie L. Bushman
78,461,093
417,437
52,825
4,467,101
Peter H. Carlin
77,686,919
1,189,287
55,149
4,467,101
Ricky T. Dillon
78,523,099
350,627
57,629
4,467,101
Jerome
J. Dorlack
78,578,179
298,946
54,230
4,467,101
Jodi E. Eddy
78,597,585
271,072
62,698
4,467,101
Richard Goodman
78,511,177
366,176
54,002
4,467,101
José M. Gutiérrez
78,095,049
778,395
57,911
4,467,101
Frederick
A. Henderson
78,377,758
485,192
68,405
4,467,101
Barb J. Samardzich
78,384,367
493,139
53,849
4,467,101
Proposal Two:
Adient’s shareholders ratified, by non-binding advisory vote, the appointment of PricewaterhouseCoopers LLP as Adient’s independent auditor for fiscal year 2024 and authorized, by binding vote, the Board of
Directors, acting through the Audit Committee, to set the auditors’ remuneration by the following vote:
For
Against
Abstain
81,821,041
1,510,377
67,038
Proposal Three:
Adient’s shareholders approved, on an advisory basis, the compensation
of Adient’s named executive officers by the following vote:
For
Against
Abstain
Broker Non-Vote
75,253,643
3,602,404
75,308
4,467,101
Proposal
Four:
Adient’s shareholders approved the renewal of the Board of Directors’ authority to issue shares under Irish law by the following vote:
For
Against
Abstain
82,061,383
1,263,000
74,073
Proposal
Five:
Adient’s shareholders approved the renewal of the Board of Directors’ authority to opt-out of statutory preemption rights under Irish law by the following vote:
For
Against
Abstain
82,499,403
819,100
79,953
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
